Despite noting the high unmet need in Duchenne muscular dystrophy, the FDA panel concluded that trial data lacked substantial evidence of the therapy's effectiveness.

A dose-escalation study in 24 healthy adults showed that an 810mL infusion produced results comparable to fresh frozen plasma without significant safety signals. The Food and Drug Administration (FDA) ...

As number of risk factors increased, increase was seen in number of plaques and plaques with vulnerable phenotype.

There was an increase in the proportion of exclusive GLP-1 RA use from 88.2% in May to November 2022 to 96.1% from June 2025 to January 2026. HealthDay News — Adolescents and young adults are ...

Shionogi’s oral main protease inhibitor Xocova (ensitrelvir) is now available in the US to reduce the risk of symptomatic ...

PLEX100, an investigational prolonged-release local doxycycline product aimed at reducing surgical site infections in patients undergoing abdominal colorectal surgery.

Following an August 2025 CRL that raised no safety or manufacturing concerns, Saol provided additional survival analyses of existing clinical data to address FDA requirements without embarking on a ...

HealthDay News — Exposure to per- and polyfluoroalkyl substances (PFAS), or “forever chemicals,” during pregnancy and early life is associated with increased intestinal inflammation during childhood, ...

HealthDay News — The 2026 American Heart Association/American College of Cardiology/multisociety guideline on the management of dyslipidemia has increased the US population recommended for primary ...

Cancer progression within 36 months of combination therapy identified patients with overall survival of less than 2 years.

Freenome's newly approved blood test offers clinicians an alternative screening option for average-risk adults aged 45 and ...

For patients with obstructive sleep apnea (OSA), hypoglossal nerve stimulation (HGNS) is associated with variable but potential long-term cardiovascular benefits, according to a study published online ...